Amy Simon - Net Worth and Insider Trading
Amy Simon Net Worth
The estimated net worth of Amy Simon is at least $3 Million dollars as of 2026-08-29. Amy Simon is the Chief Medical Officer of Beam Therapeutics Inc and owns about 85,696 shares of Beam Therapeutics Inc (BEAM) stock worth over $3 Million. Details can be seen in Amy Simon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amy Simon has not made any transactions after 2026-07-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Amy Simon
Amy Simon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amy Simon owns 1 companies in total, including Beam Therapeutics Inc (BEAM) .
Click here to see the complete history of Amy Simon’s form 4 insider trades.
Insider Ownership Summary of Amy Simon
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| BEAM | Beam Therapeutics Inc | 2026-07-27 | Chief Medical Officer |
Amy Simon Latest Holdings Summary
Amy Simon currently owns a total of 1 stock. Amy Simon owns 85,696 shares of Beam Therapeutics Inc (BEAM) as of July 27, 2026, with a value of $3 Million.
Latest Holdings of Amy Simon
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc | 2026-07-27 | 85,696 | 29.32 | 2,512,607 |
Holding Weightings of Amy Simon
Amy Simon Form 4 Trading Tracker
According to the SEC Form 4 filings, Amy Simon has made a total of 10 transactions in Beam Therapeutics Inc (BEAM) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Beam Therapeutics Inc is the sale of 16,667 shares on July 27, 2026, which brought Amy Simon around $429,009.
Insider Trading History of Amy Simon
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Amy Simon Trading Performance
Amy Simon Ownership Network
Ownership Network List of Amy Simon
Ownership Network Relation of Amy Simon
Amy Simon Owned Company Details
What does Beam Therapeutics Inc do?
Who are the key executives at Beam Therapeutics Inc?
Amy Simon is the Chief Medical Officer of Beam Therapeutics Inc. Other key executives at Beam Therapeutics Inc include director & CEO John M. Evans , 10 percent owner & other: See Remark 1 Fmr Llc , and SVP & Finance and Treasurer Bethany J Cavanagh .
Beam Therapeutics Inc (BEAM) Insider Trades Summary
Over the past 18 months, Amy Simon made 5 insider transaction in Beam Therapeutics Inc (BEAM) with a net sale of 55,553. Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 260,741 shares made by John M. Evans , a net sale of 33,257 shares made by Christine Bellon , and a net sale of 15,956 shares made by Bethany J Cavanagh .
In summary, during the past 3 months, insiders sold 351,900 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 351,900 shares. During the past 18 months, 759,738 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 759,738 shares.
Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Beam Therapeutics Inc Insider Transactions
Amy Simon Mailing Address
Above is the net worth, insider trading, and ownership report for Amy Simon. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Amy Simon's mailing address is: Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
